Literature DB >> 9031220

Analysis of data from "cold saturation" radioligand binding experiments.

W B Jeffries1, D Waugh, P W Abel.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9031220     DOI： 10.1385/0-89603-399-6:331

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


× No keyword cloud information.
  5 in total

Review 1.  Tactics for preclinical validation of receptor-binding radiotracers.

Authors:  Susan Z Lever; Kuo-Hsien Fan; John R Lever
Journal:  Nucl Med Biol       Date:  2016-09-03       Impact factor: 2.408

2.  Molecular imaging of alpha7 nicotinic acetylcholine receptors: design and evaluation of the potent radioligand [18F]NS10743.

Authors:  Winnie Deuther-Conrad; Steffen Fischer; Achim Hiller; Elsebet Østergaard Nielsen; Daniel Brunicardi Timmermann; Jörg Steinbach; Osama Sabri; Dan Peters; Peter Brust
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-10       Impact factor: 9.236

3.  Binding characterization of N-(2-chloro-5-thiomethylphenyl)-N'-(3-[3 H]3 methoxy phenyl)-N'-methylguanidine ([3 H]GMOM), a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist.

Authors:  Athanasios Metaxas; Bart N M van Berckel; Pieter J Klein; Joost Verbeek; Emily C Nash; Esther J M Kooijman; Véronique A Renjaän; Sandeep S V Golla; Ronald Boellaard; Johannes A M Christiaans; Albert D Windhorst; Josée E Leysen
Journal:  Pharmacol Res Perspect       Date:  2019-02

Review 4.  Radiolabeled antiviral drugs and antibodies as virus-specific imaging probes.

Authors:  Mike Bray; Michele Di Mascio; Fabian de Kok-Mercado; Daniel J Mollura; Elaine Jagoda
Journal:  Antiviral Res       Date:  2010-08-13       Impact factor: 5.970

5.  Cannabinoid receptor type 2 (CB2)-selective N-aryl-oxadiazolyl-propionamides: synthesis, radiolabelling, molecular modelling and biological evaluation.

Authors:  Thomas Rühl; Winnie Deuther-Conrad; Steffen Fischer; Robert Günther; Lothar Hennig; Harald Krautscheid; Peter Brust
Journal:  Org Med Chem Lett       Date:  2012-10-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.